TRIP National office for hemovigilance and biovigilance, The Netherlands
TRIP stands for “Transfusion and Transplantation Reactions in Patients”. Our mission is to receive and analyse reports of adverse reactions and adverse events associated with blood transfusion or with the application of human tissues or cells. TRIP also promotes hemovigilance and biovigilance in the widest sense, throughout the chain from donor to recipient, in order to contribute to improved safety of transfusion and transplantation in The Netherlands.
Read articles from the Blood Components Working Party and get to know our new ISBTPresident, Lin Fung, a little better. All in this quarter's issue of Transfusion Today. 🩸